Related Experiment Video
Updated: Jan 16, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Knowledge and Patterns Related to Nasal Decongestant Use Among the General Population in the Jazan Region of Saudi
Khalil I Kariri1, Hadi M Mokarbesh1, Abdulrahman A Otaif2
1Otolaryngology, King Fahd Central Hospital, Jazan, SAU.
Background:
Although nasal decongestants are commonly used to treat respiratory symptoms, their inappropriate use may lead to complications such as rhinitis medicamentosa. There is a lack of research examining patterns of use and knowledge in Saudi Arabia, particularly in the Jazan Region.
Aim:
This study aimed to evaluate the knowledge, patterns, and factors related to nasal decongestant use among adults in the Jazan Region of Saudi Arabia.
Methods:
A cross-sectional study was conducted between January and June 2024. Data were collected through an online survey distributed via social media platforms. The validated Arabic online questionnaire collected data on the sociodemographic profile, patterns of use, and knowledge of nasal decongestants from 439 participants aged 18 years and above. Appropriate use was defined as obtaining the medication from healthcare facilities or using it for less than five days with a maximum of three doses per day. The data were analyzed descriptively and using bivariate and multivariate logistic regression models.
Results:
The participants were predominantly young (average age, 27.8 years), female (65.4%), and university educated (67.9%). Of the 312 users, 57.1% demonstrated an appropriate duration of use (less than five days), and 42.9% exceeded the recommended duration of use. Regarding concerning patterns, 75% procured decongestants illegally from pharmacies and 25% self-medicated. There were significant knowledge gaps, with only 35.5% of participants aware of the rebound congestion risk and 43.1% incorrectly believing that decongestants were safe for all children. A strong dose-response relationship was observed between knowledge and appropriate use, with 32.1% and 71.2% for the low and high knowledge tertiles, respectively (p < 0.001). Employment in healthcare (adjusted odds ratio (AOR) = 2.45; p < 0.001) and postgraduate qualifications (AOR = 3.21; p = 0.003) were the strongest predictors of appropriate usage. The rate of complications significantly increased with a duration of use greater than seven days (risk ratio (RR) = 5.63; 95% CI: 2.17-14.59).
Conclusions:
Significant knowledge gaps and patterns of inappropriate nasal decongestant use were observed among the residents of Jazan. There is a need for tailored educational strategies that address appropriate usage, duration, healthcare worker status, and raters with lower levels of educational attainment.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
Related Concept Videos
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Nose and Nasal Cavity
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...